Stock ARALEZ PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Aralez Pharmaceuticals Inc Nasdaq

Equities

CA03852X1006

End-of-day quote Nasdaq
Other stock markets
- - Intraday chart for Aralez Pharmaceuticals Inc
2019 Old API Wind-Down Ltd. Announces Management Changes CI
2019 Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Aralez Pharmaceuticals Inc. has Changed its Name to Old API Wind-down Ltd
CI
Aralez Pharmaceuticals Inc. Announces Management Changes
CI
Aralez Pharmaceuticals Inc. Announces the Resignation of Seth A. Rudnick, Neal F. Fowler and Rob Harris as Directors
CI
Aralez Pharmaceuticals Inc. Announces Resignation of James Tursi as Chief Medical Officer, Effective from August 2, 2018
CI
Aralez Pharmaceuticals Inc. Announces Resignation of Mark Glickman as Chief Commercial Officer, Effective on March 30, 2018
CI
Aralez Pharmaceuticals Inc. Appoints Michael Kaseta as Chief Financial Officer
CI
Aralez Pharmaceuticals Inc. Announces Resignation of Jason M. Aryeh as Board Member
CI
Aralez Pharmaceuticals Inc. Appoints James L. Hall as General Manager of Tribute, Effective May 16, 2016
CI
Aralez Pharmaceuticals Inc. Announces Board Changes
CI
POZEN Inc. Announces Management Changes
CI
POZEN Inc. Announces Executive Changes
CI
POZEN Inc. Appoints Scott Charles Senior Vice President of Finance
CI
POZEN Inc. Announces Executive Appointments
CI
POZEN Inc. Announces Management Changes
CI
POZEN Inc. Promotes Dennis McNamara to Senior Vice President and Chief Business Officer
CI
POZEN Announces Retirement of Elizabeth Cermak as Executive Vice President and Chief Commercial Officer, Effective January 1, 2014
CI
Jacques Rejeange to Resign as Board of Director of POZEN Inc
CI
POZEN Inc. Announces Retirement of Tom S Bocanegra as Executive Vice President, Development of the Company, Effective October 31, 2012
CI
POZEN Inc. Announces Intension of James J. Mauzey and Angela M. Larson Not to Stand for Reelection as Class III Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ARLZQ Stock
  4. Stock
  5. News Aralez Pharmaceuticals Inc
  6. Insiders